Bank of America Securities analyst Victoria Petrova has maintained their bullish stance on HLN stock, giving a Buy rating on November 4.

Given the lack of innovation and over-reliance on existing products, I recommend a "sell" rating for Haleon, questioning its standalone success and justification for current valuation. GSK chose ...

A New York federal judge on Tuesday dismissed about 100 lawsuits that claimed Procter & Gamble , Haleon and other companies ...

Revenue missed analyst estimates by 2.5%. Earnings per share (EPS) exceeded analyst estimates by 12%. Looking ahead, revenue ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

The Haleon brands that were “Certified Inclusive” by the first SeeMe Health & Wellness Index include two other pain relief products -- Advil and Voltaren – along with Theraflu. Advil ...

Haleon plc (LON:HLN) came out with its third-quarter results last week, and we wanted to see how the business is performing and what industry forecasters think of the company following this report ...

Despite pressure on consumer spending, consumers prioritise trusted brands for their health-related needs and Haleon is a ...

Haleon PLC (HLN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on October 31. Analyst David ...

Haleon named Vistar Media, a location-based ad technology company, as its preferred partner for programmatic out-of-home (OOH) advertising across all key markets. As part of the partnership announced ...